LIXIVAPTAN
Lixivaptan (VPA-985) is a potent and selective vasopressin V2 receptor antagonist with a Ki of 2.3 nM. It is an orally bioavailable research tool used in vitro and in vivo to study mechanisms of aquaresis and conditions like hyponatremia and heart failure.
Product Specifications
CAS Number
168079-32-1
Product Name Alternative
Inhibitor, inhibit, LIXIVAPTAN, WAY-VPA 985, WAY-VPA985, WAY-VPA-985, VasopressinReceptor, Vasopressin Receptor, VPA 985, VPA985, VPA-985
Field of Research
Pharmacology & Drug Discovery
Purity
98.36% (May vary between batches)
Solubility
10% DMSO+40% PEG300+5% Tween 80+45% Saline:4 mg/mL (8.44 mM) ; DMSO:150 mg/mL (316.5 mM)
Smiles
Cc1ccc (F) cc1C (=O) Nc1ccc (C (=O) N2Cc3cccn3Cc3ccccc23) c (Cl) c1
Molecular Formula
C27H21ClFN3O2
Molecular Weight
473.93
Storage Conditions
-20°C
Notes
For research use only.
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
BNC882059-500 1x 500 µL
TNFS15 / VEGI (Vascular Endothelial Growth Inhibitor) (rVEGI/1283), CF488A conjugate, 0.1mg/mL
Sign In for Pricing
View Details 
TP317977 20 µg
BAF53A (ACTL6A) (NM_004301) Human Recombinant Protein
Sign In for Pricing
View Details 
